国际麻醉学与复苏杂志   2014, Issue (5): 7-7
    
右美托咪定对子宫切除术后地佐辛自控镇痛效果的影响
徐尚军, 陈东升, 周国庆1()
1.首都医科大学平谷医院
Effect of dexmedetomidine on postoperative pain in patients receiving patient controlled intravenous analgesia with dezocine after hysterectomy
 全文:
摘要:

目的 探讨右美托咪定(dexmedetomidine, Dex)对子宫切除术后地佐辛患者自控静脉镇痛效果的影响。 方法 择期拟行经腹子宫切除术的患者60例,年龄40岁~65岁,身高155 cm~170 cm,体重49 kg~75 kg,美国麻醉医师学会(ASA)分级Ⅰ或Ⅱ级,采用随机数字表法分为两组(每组30例):地佐辛组(D组)、Dex和地佐辛组(DD组)。DD组术毕前30 min缓慢静脉泵注(15 min)Dex 0.8 μg/kg,D组静脉给予同等容量的生理盐水。两组均在术毕前10 min静脉注射地佐辛5 mg、托烷司琼2 mg,手术结束后行地佐辛患者自控静脉镇痛,地佐辛30 mg、托烷司琼8 mg用生理盐水稀释至150 ml,背景输注速率3 ml/h,自控给药剂量3 ml,锁定时间15 min。于术后4、8、24 、48 h 记录视觉模拟评分(viaual analogue scale, VAS)、镇静评分(ramsay sedation scores)、追加镇痛药例数、镇痛泵按压次数;记录术后48 h内恶心、呕吐、瘙痒、心动过缓、低血压和呼吸抑制等副作用发生情况。 结果 DD组术后4、8 h VAS评分[2(1~2)、2(1~2)]和镇痛泵按压次数[1(0~1)、0(0~1)]均低于同时点D组[3(2~3)、2(2~3)]和[1(1~2)、1(0~2)](P<0.05)。DD组术后48 h内恶心、呕吐的发生率3%、0%明显低于D组10%、3% (P<0.05)。 结论 术毕前30 min缓慢静脉泵注(15 min)Dex 0.8 μg/kg可增强地佐辛患者自控静脉镇痛效果,且副作用少。

关键词: 右美托咪定;地佐辛;镇痛;患者自控
Abstract:

Objective To evaluate the effect of dexmedetomidine(Dex) on postoperative pain in patients receiving patient controlled intravenous analgesia with dezocine after hysterectomy. Methods Sixty ASA Ⅰ or Ⅱ patients undergoing elective abdominal hysterectomy,aged 40 y-65 y,weighing 49 kg-75 kg were randomly divided into 2 groups (n=30): group dezocine (group D), group Dex and dezocine (group DD). Dezocine 5 mg and tropisetron 2 mg were given in both groups at 10 min before the end of the operation. Patient controlled intravenous analgesia was performed with dezocine 30 mg+tropisetron 8 mg in 150 ml of normal saline after operation (background infusion at 3 ml/h with a bolus dose of 3 ml and a 15 min lockout interval). Dex 0.8 μg/kg was given in 15 min in group DD by pumped infusion 30 min before the operation finished,while normal saline was given in group D. Viaual analogue scale(VAS), Ramsay sedation scores, the number of patiengs requiring rescue analgesics and the number of pressing the patient controlled intravenous analgesia button were recorded at 4, 8, 24, 48 h after operation. Postoperative complications including nausea,vomiting,itching,bradycardia,hypotension,and respiratory depression were recorded. Results The VAS scores and times of pressing the patient controlled intravenous analgesia button were lower at 4 h and 8 h after surgery in group DD [2(1-2), 2(1-2)] and [1(0-1), 0(0-1)] than in group D [3(2-3), 2(2-3)] and [1(1-2), 1(0-2)](P<0.05). The incidence of nausea and vomiting in group DD [3%, 0%] was less than the group D [10%, 3%] after surgery (P<0.05). Conclusions Dex with a single dose of 0.8 μg/kg (given 15 min by pumped infusion) 30 min before operation finished can significantly improve the postoperative analgesic effect of patient controlled intravenous analgesia with dezocine with less adverse effects.

Key words: Dexmedetomidine;Dezocine;Analgesia;Patient-controlled